EPO and anemia: The observation that recombinant EPO improves the exercise capacity of anemic hemodialyzed patients who were still transfusion independent [87] paved the way to devise therapeutic uses for EPO to improve the quality of life of patients with a great variety of pathological conditions, ranging from the anemia of the elderly caused by chronic inflammation to that sustained by the chemotherapy used to halt disease progression in cancer patients.